Latest Biotechnology, Pharmaceutical and Healthcare News

12:35 EDT 1st April 2015 | BioPortfolio

Showing News Articles 1–25 of 400,000+

Wednesday 1st April 2015

BioPharm Veteran on DelMar Board

DelMar Pharmaceuticals, Inc., today announced that it has appointed biopharmaceutical industry veteran, Erich Mohr, Ph.D., R.Psych., to its Board of Directors as an independent director. Dr. Mohr has close to two decades of biotechnology experie...

Panther Biotechnology In Exclusive License Agreement With Northwestern University

Panther Biotechnology, Inc., a biotechnology company specializing in the development of enhanced therapeutics for the treatment of neoplastic and autoimmune disorders, is pleased to announce today that it has entered into an exclusive global license ...

Kissei partners with Ajinomoto Pharma on ulcerative colitis candidates

Japanese drugmaker Kissei Pharmaceutical has entered into a partnership with Ajinomoto Pharmaceuticals…

GrassrootsHealth Launches CME Courses about Vitamin D

Practitioners completing both courses receive D*certification San Diego, CA (PRWEB) April 01, 2015 GrassrootsHealth, an international nonprofit public health promotion organization, is announcing two continuing medical education (CME) courses about vitamin D. The goal is to help practitioners become more confident in measuring, prescribing, and tracking vitamin D levels to prevent disease. After ...

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study

Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer

The oncomiR miR-197 is a novel prognostic indicator for non-small cell lung cancer patients

Reply: Comment on ‘Vitamin D supplements and cancer incidence and mortality: a meta-analysis’

Comment on: ‘Vitamin D supplements and cancer incidence and mortality: a meta-analysis’

Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research

Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer

C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer

IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer

The combination of axitinib followed by paclitaxel/carboplatin yields extended survival in advanced BRAF wild-type melanoma: results of a clinical/correlative prospective phase II clinical trial

Russian government approves new plan for pharma import substitution

The Russian government plans to approve a new plan of import substitution in the national pharmaceutical…

Park Systems Awarded the New Economy Magazine “Best Analytic Instrumentation Company 2014”

Park Systems, world-leader in Atomic Force Microscopes (AFM) was selected to receive the prestigious “Best Analytic Instrumentation Company Award 2014” by The New Economy Magazine. Park NX10 is the premium research-grade True Non-Contact AFM, featuring industry-leading Z-servo speed, XY and Z scanner linearity, closed-loop detector noise, and minimized thermal drift. Coupled with the latest fe...

NEC Display Solutions Receives FDA 510(K) Clearance on MD322C8 Review Monitor

Eight-Megapixel 32-Inch Color Display is Ideal for Diagnostic Review NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today Food and Drug Administration 510(K) market clearance of the MultiSync® MD322C8 LCD, a high resolution display for

CEP America Begins Staffing Inpatient Department at Feather River Hospital

CEP America, one of the nation’s leading providers of hospital-based physician management solutions, is pleased to announce the expansion of its partnership with Feather River Hospital in Paradise, Calif. After seeing operational improvements in the emergency department (ED) with CEP America for five years, hospital administrators selected CEP America to...

Ipsen Expands Ties to Harvard University with Signing of a New Research Alliance Agreement

Regulatory News: Ipsen (Euronext: IPN, ADR: IPSEY) announced today that it has signed a multi-year research alliance agreement with Harvard University in Cambridge, Mass. Designed to stimulate new research projects, the alliance will enable researchers at Ipsen and Harvard to identify and develop collaborative programs in the areas...

GeoVax HIV Vaccine Moves Forward

GeoVax Labs, a biotechnology company developing human vaccines for Ebola and HIV, today announced that the HIV Vaccine Trials Network (HVTN) has assigned a trial number, HVTN 114, to the next clinical trial of its clade B preventive HIV vaccine cand...

Novo Nordisk aims further expansion in Russia

Danish diabetes care giant Novo Nordisk (NOV: N) plans to continue its expansion in the Russian pharmaceutical…

FDA approves new formulation of Novartis' iron overload product

The US Food and Drug Administration has approved Jadenu (deferasirox), manufactured by Swiss drug major…

Changing patients’ lives via technology

‘The patient will see you now’ by Eric Topol.

Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry

Columbia, Maryland dentist Dr. Daniel C. Stewart now offers patients from Howard County an alternative to conventional gum surgery in the form of the LANAP® protocol. This laser surgery available at Dr. Stewart's practice, Smile Savers Dentistry, is a minimally invasive gum disease treatment that offers patients minimal pain and a fast healing period, along with all of the health benefits...

Merck Serono gains right to antimalarial compound

German Merck KGaA biopharma subsidiary Merck Serono has reached agreement with Medicines for Malaria…


Search BioPortfolio:
Loading
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.